Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04298658 · ClinicalTrials.gov registry record
The Impact of Insomnia on Pain in HIV
A clinical trial, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 171
- Enrollment target
NCT04298658 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 171 participants.
The verdict
NCT04298658 has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
Study Summary
The overall objective of this application is to investigate the impact of insomnia on pain, physical functioning, and inflammation in people living with HIV. The two aims of this study to determine 1) whether insomnia promotes increased sensitivity and inflammatory reactivity to pain stimuli, and 2) if weekly fluctuations in insomnia burden drive changes in inflammation, pain severity, and physical functioning in people living with HIV. This research could help confirm insomnia as a therapeutic target for the suppression of pain and inflammation in people living with HIV.
Interventions
- DIAGNOSTIC_TEST Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)sleep disorders-revised
- DIAGNOSTIC_TEST Resmed ApneaLink Air device (Resmed, San Diego, CA).
- OTHER Quantitative Sensory testing (QST)
- DIAGNOSTIC_TEST OraQuick Advance Rapid HIV 1/2 Swab test
- DIAGNOSTIC_TEST Cluster of Differentiation 4 (CD4) and Viral load
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2025-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04298658
The ClinicalTrials.gov registry entry for NCT04298658 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)sleep disorders-revised is the first listed.
NCT04298658 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04298658 about?
NCT04298658 is a clinical study titled "The Impact of Insomnia on Pain in HIV". The overall objective of this application is to investigate the impact of insomnia on pain, physical functioning, and inflammation in people living with HIV. The two aims of this study to determine 1) whether insomnia promotes increased sensitivity and inflammatory reactivity to pain stimuli, and 2)...
What is the current status of trial NCT04298658?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2020-01-01. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT04298658?
The interventions under investigation include: Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5)sleep disorders-revised (DIAGNOSTIC_TEST), Resmed ApneaLink Air device (Resmed, San Diego, CA). (DIAGNOSTIC_TEST), Quantitative Sensory testing (QST) (OTHER), OraQuick Advance Rapid HIV 1/2 Swab test (DIAGNOSTIC_TEST), Cluster of Differentiation 4 (CD4) and Viral load (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04298658?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.